Navigation Links
Beckman Coulter Affirms 2009 Outlook
Date:12/17/2009

uld cause actual results and events to differ materially from those stated in the forward-looking statements. These risks and uncertainties include our ability to effectively integrate and realize the anticipated effects of the ODS acquisition; our ability to compete effectively; changes in laws and regulations, including pending healthcare reform; market demand for the company's new and existing products; intellectual property infringement claims by others and our ability to protect the company's intellectual property; difficulty in obtaining materials and components for our products; consolidation of our customer base, formation of group purchasing organizations and changes in customer inventory levels and inventory management practices; reductions in government funding to our customers; foreign currency exchange fluctuations; global market, economic and political conditions and natural disasters; costs associated with our supply chain initiatives; tax risks and regulations; changes in the value of our investment in marketable securities; and our ability to successfully acquire and integrate acquired businesses and realize the anticipated benefits from such acquisitions. Additional factors that could cause actual results to differ are discussed in Part I, Item 1A (Risk Factors) of the company's Form 10-K filed with the SEC on February 23, 2009 as well as in the company's Form 10-Q filed since then and reports on Form 8-K. Forward-looking statements contained in this press release are made only as of the date hereof, and we undertake no obligation to update these disclosures except as required by law.


    Contact:          Cynthia Skoglund                (714) 961-6320
                      Manager, Investor Relations

SOURCE Beckman Coulter, Inc.


'/>"/>
SOURCE Beckman Coulter, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Beckman Coulter to Present at the 2009 Piper Jaffray Healthcare Conference
2. Beckman Coulter Announces Conference Call and Webcast of Accompanying Slides in Conjunction With Third Quarter 2009 Earnings
3. Beckman Coulter Announces Third Quarter 2009 Results
4. Beckman Coulter to Present at Upcoming Healthcare Conferences
5. Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers
6. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
7. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
8. Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
9. Accumetrics Closes 2009 with Positive Outlook
10. Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities
11. Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Tianyin Pharmaceutical Co., Inc. (NYSE Amex: ... specializes in patented biopharmaceutical, modernized traditional Chinese medicine ... today updates the timeline for the GMP certification ... The Company is scheduled to submit the ... & Drug Administration,s (CFDA) review in the week ...
(Date:8/28/2014)... SALT LAKE CITY , Aug. 28, 2014 /PRNewswire-iReach/ ... in 2000 by service academy graduates, has published a ... its concentrated, three-day Leadership Excellence Course . In ... the  Leadership Excellence Course to Albuquerque , ... Tucson . Photo - http://photos.prnewswire.com/prnh/20140828/140814 ...
(Date:8/28/2014)... Nonin Medical, Inc., the inventor of finger ... today announced that the Food and Drug Administration (FDA) ... oximeter for use in the United States ... telemedicine hub or kiosk through a USB connector and ... adult patients. The Model 3231 received EU certification last ...
Breaking Medicine Technology:TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2
... Xenogenics Corporation ("Xenogenics"), a majority owned subsidiary of ... to announce it has retained the Emmes Group to ... formation strategy to help finance expanded human clinical trials ... testing and initial human use, the Ideal BioStent™ demonstrated ...
... Biosciences, a privately held company leading the development of ... McDonald, MBA, Senior Vice President and Chief Business Officer, ... will highlight new and innovative cardiovascular drug therapies at ... discussion will be held at the New York Palace ...
Cached Medicine Technology:Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts 2Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts 3Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts 4Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City 2Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City 3
(Date:8/29/2014)... across the Arabian Peninsula and spread to Europe several ... of several hundred people since its discovery in 2012. ... how easily the pathogen spreads from human to human. ... the University of Bonn have now come to the ... transmission is low. Still, a third of infected persons ...
(Date:8/29/2014)... Glendale Botox experts at Glenoaks Laser Center are ... of September. This special offer features 10 free units of ... can take advantage of this special offer to completely transform ... work with patients to determine if Botox or Juvederm is ... , Botox is a treatment made from the botulinum toxin. ...
(Date:8/29/2014)... VHA Central Atlantic recognized Novant Health ... honoring nine facilities for meeting or exceeding national performance ... Health, providing quality, affordable healthcare for our communities has ... executive vice president and chief medical officer. “These awards ... for each and every one of our patients.” , ...
(Date:8/29/2014)... TX (PRWEB) August 29, 2014 PreDiabetes ... off the fall season by offering Web shoppers a 20% ... PreD Store , the Company’s online healthy living shop, beginning ... should be top priority when heading into the chilly fall ... lifestyle habits. During this season, people usually ditch the healthy ...
(Date:8/29/2014)... August 29, 2014 Many Americans are ... keep diabetes type 2 at bay, patients should consider ... make the necessary lifestyle changes. While some diabetes risk ... history, advanced age, or belonging to certain ethnic groups, ... – their weight. Carrying extra pounds, especially in the ...
Breaking Medicine News(10 mins):Health News:MERS: Low transmissibility, dangerous illness 2Health News:MERS: Low transmissibility, dangerous illness 3Health News:Glenoaks Laser Center is Now Offering a Special Promotion on Botox for the Month of September 2Health News:Novant Health Recognized for Excellence in Clinical Care 2Health News:Novant Health Recognized for Excellence in Clinical Care 3Health News:PreDiabetes Centers Online Store Launches Fall Savings Event 2Health News:Diet Doc Announces Specialized Diet Plans that Help Patients Prevent Diabetes by Stabilizing Blood Sugar Levels and Losing Excess Fat 2Health News:Diet Doc Announces Specialized Diet Plans that Help Patients Prevent Diabetes by Stabilizing Blood Sugar Levels and Losing Excess Fat 3
... has led to the development of proposals to dump about 800 ... end of the month. ,The move follows the ... six months should stay on a list. ,Patients ... within six months are referred back to their GP for monitoring. ...
... have identified key compounds that stimulate stem cell growth ... is set to appear in the September 2006 issue ... one day lead to restored function for people who ... sclerosis, and a wide range of neurological disorders. The ...
... doctors in North Karnataka, cautioned by the health and ... and not to harass them. // ,The ... take action against doctors harassing and denying treatment to ... of the first anniversary celebration of ‘Ashodaya’, which is ...
... to launch a new vaccination project to protect ... vaccination against pneumococcal meningitis will also be integrated ... meningitis is very serious," Diane McConnell, manager of ... die or be left with very severe after ...
... nitrogen-containing compounds that food producers use to cure meats may ... says a new study. // ,Previous studies have found ... study by Graham Barr at Columbia University Medical Center in ... the affect on lung function in humans, reported the online ...
... Mukesh Haikerwal, today urged all Australians to think about ... desire to donate organs.// ,Research published in the ... for transplant are harvested from only a fraction of ... found that, in many instances, organs are not donated ...
Cached Medicine News:Health News:800 Patients to be Dumped from Hospital Waiting Lists 2Health News:Action Against Doctors Harassing HIV/AIDS Patients 2Health News:AMA Urges Organ Donors to Speak Up 2
... Dehydroepiandrosterone sulfate (DHEA-S) is the sulfate ... and by enzymatic conversion of DHEA in ... major C19 steroid secreted by the adrenal ... and estrogen biosynthesis. DHEA possesses relatively weak ...
... Dehydroepiandrosterone sulfate (DHEA-S) is the sulfate ... and by enzymatic conversion of DHEA in ... major C19 steroid secreted by the adrenal ... and estrogen biosynthesis. DHEA possesses relatively weak ...
... sulfate ester of DHEA, derived from sulfated ... in adrenal and extradrenal tissues. DHEA is ... adrenal cortex, and is a precursor for ... weak androgenic activity, which for unsulfated DHEA ...
... kit is based on the competition principle ... of DHEA-S present in the sample and ... horse-radish peroxidase compete for the binding sites ... the wells. After one hour incubation the ...
Medicine Products: